| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.15 | 0.0008 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |